huvec cell specific medium Search Results


huvecs  (ATCC)
99
ATCC huvecs
Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pm35137664-47-0-1?v=ATCC
Average 99 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics huvec complete growth medium icell–h110–001b
Huvec Complete Growth Medium Icell–H110–001b, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc10848469-60-22-26?v=iCell+Gene+Therapeutics
Average 90 stars, based on 1 article reviews
huvec complete growth medium icell–h110–001b - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cleaver Scientific huvec culture medium
Huvec Culture Medium, supplied by Cleaver Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/10__1039_slash_c7lc00926g-178-0-34?v=Cleaver+Scientific
Average 90 stars, based on 1 article reviews
huvec culture medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
AllCells LLC huvec medium
Huvec Medium, supplied by AllCells LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pm39197208-74-20-23?v=AllCells+LLC
Average 90 stars, based on 1 article reviews
huvec medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza endothelial basal medium-2 basal medium
Endothelial Basal Medium 2 Basal Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc04101738-44-7-13?v=Lonza
Average 90 stars, based on 1 article reviews
endothelial basal medium-2 basal medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ScienCell ecm 1001 endothelial cell medium
Ecm 1001 Endothelial Cell Medium, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pm40429988-230-6-5?v=ScienCell
Average 90 stars, based on 1 article reviews
ecm 1001 endothelial cell medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza huvecs
Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc06968943-127-35-36?v=Lonza
Average 90 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza egm-2 bullet kit
Egm 2 Bullet Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/10__1016_slash_j__matlet__2019__03__137-30-6-15?v=Lonza
Average 90 stars, based on 1 article reviews
egm-2 bullet kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza huvec culture medium
Huvec Culture Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/us09532956-1037-9-12?v=Lonza
Average 90 stars, based on 1 article reviews
huvec culture medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
InSCREENeX gmbh hulec medium
a Effects of recombinant human (rh)GDF-15 (added for 10 min) on CXCL12α−mediated adhesion of whole blood-derived CD45 + cells to activated human lymphatic endothelial <t>cells</t> <t>(huLEC)</t> were analyzed. Adherence was calculated based on the number of CD45 + cells as enumerated by flow cytometry ( n = 7 experiments). In b , adhering leukocytes were further characterized by multicolor staining ( n = 10 experiments). c Stimulated T cells from 6 donors were treated or not with rhGDF-15 for 20 min before being run in µ-slides over a layer of activated huLEC. 10 predefined fields of view were video-imaged for 5 s and the number of T cells adhering under hydrodynamic flow conditions was counted. Different shadings indicate different T cell donors. For reference, adhesion to non-activated huLEC is shown for one donor. d Enumeration of T cells adhering to human umbilical vein endothelial cells <t>(HUVEC).</t> 5 predefined fields of view per sample were analyzed in a representative experiment. In e , CXCL9 and CXCL10 were used to induce adhesion of untreated or GDF-15-treated CD8 + T cells from 3 different donors on stimulated huLEC. In f , stimulated CD8 + T cells from 3 different donors were treated with rhGDF-15 and anti-GFRAL or isotype control antibodies for 20 min before being run in µ-slides over a layer of activated huLEC. In g – j , phase-contrast microscopy in chamber slides to assess effects of rhGDF-15 on T cell adhesion to activated HUVEC. An EC 50 value for rhGDF-15-mediated adhesion inhibition on pan T cells from 3 different donors was determined in g (logICF=logIC50 + (1/HillSlope)*log(F/(100-F)). h – j Using pan T cells from 9 different donors, effects of rhGDF-15 on T cell adhesion ( h ), transmigration ( i ) and recruitment ( j ) were analyzed. Statistical analyses were performed by one-way ANOVA in a , d , f , by two-sided paired Student´s t -tests in b , e , h , i , j , by mixed-effects analysis in c . To correct for multiple comparisons, Tukey´s post hoc test was applied in a , c , d , Bonferroni´s method in b . In c , d , g , mean values with SEM, in e , f , median values are indicated as horizontal lines. Source data are provided as a Source Data file.
Hulec Medium, supplied by InSCREENeX gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc10359308-328-10-12?v=InSCREENeX+gmbh
Average 90 stars, based on 1 article reviews
hulec medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
AllCells LLC huvec basal medium supplement
a Effects of recombinant human (rh)GDF-15 (added for 10 min) on CXCL12α−mediated adhesion of whole blood-derived CD45 + cells to activated human lymphatic endothelial <t>cells</t> <t>(huLEC)</t> were analyzed. Adherence was calculated based on the number of CD45 + cells as enumerated by flow cytometry ( n = 7 experiments). In b , adhering leukocytes were further characterized by multicolor staining ( n = 10 experiments). c Stimulated T cells from 6 donors were treated or not with rhGDF-15 for 20 min before being run in µ-slides over a layer of activated huLEC. 10 predefined fields of view were video-imaged for 5 s and the number of T cells adhering under hydrodynamic flow conditions was counted. Different shadings indicate different T cell donors. For reference, adhesion to non-activated huLEC is shown for one donor. d Enumeration of T cells adhering to human umbilical vein endothelial cells <t>(HUVEC).</t> 5 predefined fields of view per sample were analyzed in a representative experiment. In e , CXCL9 and CXCL10 were used to induce adhesion of untreated or GDF-15-treated CD8 + T cells from 3 different donors on stimulated huLEC. In f , stimulated CD8 + T cells from 3 different donors were treated with rhGDF-15 and anti-GFRAL or isotype control antibodies for 20 min before being run in µ-slides over a layer of activated huLEC. In g – j , phase-contrast microscopy in chamber slides to assess effects of rhGDF-15 on T cell adhesion to activated HUVEC. An EC 50 value for rhGDF-15-mediated adhesion inhibition on pan T cells from 3 different donors was determined in g (logICF=logIC50 + (1/HillSlope)*log(F/(100-F)). h – j Using pan T cells from 9 different donors, effects of rhGDF-15 on T cell adhesion ( h ), transmigration ( i ) and recruitment ( j ) were analyzed. Statistical analyses were performed by one-way ANOVA in a , d , f , by two-sided paired Student´s t -tests in b , e , h , i , j , by mixed-effects analysis in c . To correct for multiple comparisons, Tukey´s post hoc test was applied in a , c , d , Bonferroni´s method in b . In c , d , g , mean values with SEM, in e , f , median values are indicated as horizontal lines. Source data are provided as a Source Data file.
Huvec Basal Medium Supplement, supplied by AllCells LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc02756210-62-30-34?v=AllCells+LLC
Average 90 stars, based on 1 article reviews
huvec basal medium supplement - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza medium huvecs
a Effects of recombinant human (rh)GDF-15 (added for 10 min) on CXCL12α−mediated adhesion of whole blood-derived CD45 + cells to activated human lymphatic endothelial <t>cells</t> <t>(huLEC)</t> were analyzed. Adherence was calculated based on the number of CD45 + cells as enumerated by flow cytometry ( n = 7 experiments). In b , adhering leukocytes were further characterized by multicolor staining ( n = 10 experiments). c Stimulated T cells from 6 donors were treated or not with rhGDF-15 for 20 min before being run in µ-slides over a layer of activated huLEC. 10 predefined fields of view were video-imaged for 5 s and the number of T cells adhering under hydrodynamic flow conditions was counted. Different shadings indicate different T cell donors. For reference, adhesion to non-activated huLEC is shown for one donor. d Enumeration of T cells adhering to human umbilical vein endothelial cells <t>(HUVEC).</t> 5 predefined fields of view per sample were analyzed in a representative experiment. In e , CXCL9 and CXCL10 were used to induce adhesion of untreated or GDF-15-treated CD8 + T cells from 3 different donors on stimulated huLEC. In f , stimulated CD8 + T cells from 3 different donors were treated with rhGDF-15 and anti-GFRAL or isotype control antibodies for 20 min before being run in µ-slides over a layer of activated huLEC. In g – j , phase-contrast microscopy in chamber slides to assess effects of rhGDF-15 on T cell adhesion to activated HUVEC. An EC 50 value for rhGDF-15-mediated adhesion inhibition on pan T cells from 3 different donors was determined in g (logICF=logIC50 + (1/HillSlope)*log(F/(100-F)). h – j Using pan T cells from 9 different donors, effects of rhGDF-15 on T cell adhesion ( h ), transmigration ( i ) and recruitment ( j ) were analyzed. Statistical analyses were performed by one-way ANOVA in a , d , f , by two-sided paired Student´s t -tests in b , e , h , i , j , by mixed-effects analysis in c . To correct for multiple comparisons, Tukey´s post hoc test was applied in a , c , d , Bonferroni´s method in b . In c , d , g , mean values with SEM, in e , f , median values are indicated as horizontal lines. Source data are provided as a Source Data file.
Medium Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec+cell+specific+medium/pmc03578017-221-3-6?v=Lonza
Average 90 stars, based on 1 article reviews
medium huvecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a Effects of recombinant human (rh)GDF-15 (added for 10 min) on CXCL12α−mediated adhesion of whole blood-derived CD45 + cells to activated human lymphatic endothelial cells (huLEC) were analyzed. Adherence was calculated based on the number of CD45 + cells as enumerated by flow cytometry ( n = 7 experiments). In b , adhering leukocytes were further characterized by multicolor staining ( n = 10 experiments). c Stimulated T cells from 6 donors were treated or not with rhGDF-15 for 20 min before being run in µ-slides over a layer of activated huLEC. 10 predefined fields of view were video-imaged for 5 s and the number of T cells adhering under hydrodynamic flow conditions was counted. Different shadings indicate different T cell donors. For reference, adhesion to non-activated huLEC is shown for one donor. d Enumeration of T cells adhering to human umbilical vein endothelial cells (HUVEC). 5 predefined fields of view per sample were analyzed in a representative experiment. In e , CXCL9 and CXCL10 were used to induce adhesion of untreated or GDF-15-treated CD8 + T cells from 3 different donors on stimulated huLEC. In f , stimulated CD8 + T cells from 3 different donors were treated with rhGDF-15 and anti-GFRAL or isotype control antibodies for 20 min before being run in µ-slides over a layer of activated huLEC. In g – j , phase-contrast microscopy in chamber slides to assess effects of rhGDF-15 on T cell adhesion to activated HUVEC. An EC 50 value for rhGDF-15-mediated adhesion inhibition on pan T cells from 3 different donors was determined in g (logICF=logIC50 + (1/HillSlope)*log(F/(100-F)). h – j Using pan T cells from 9 different donors, effects of rhGDF-15 on T cell adhesion ( h ), transmigration ( i ) and recruitment ( j ) were analyzed. Statistical analyses were performed by one-way ANOVA in a , d , f , by two-sided paired Student´s t -tests in b , e , h , i , j , by mixed-effects analysis in c . To correct for multiple comparisons, Tukey´s post hoc test was applied in a , c , d , Bonferroni´s method in b . In c , d , g , mean values with SEM, in e , f , median values are indicated as horizontal lines. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

doi: 10.1038/s41467-023-39817-3

Figure Lengend Snippet: a Effects of recombinant human (rh)GDF-15 (added for 10 min) on CXCL12α−mediated adhesion of whole blood-derived CD45 + cells to activated human lymphatic endothelial cells (huLEC) were analyzed. Adherence was calculated based on the number of CD45 + cells as enumerated by flow cytometry ( n = 7 experiments). In b , adhering leukocytes were further characterized by multicolor staining ( n = 10 experiments). c Stimulated T cells from 6 donors were treated or not with rhGDF-15 for 20 min before being run in µ-slides over a layer of activated huLEC. 10 predefined fields of view were video-imaged for 5 s and the number of T cells adhering under hydrodynamic flow conditions was counted. Different shadings indicate different T cell donors. For reference, adhesion to non-activated huLEC is shown for one donor. d Enumeration of T cells adhering to human umbilical vein endothelial cells (HUVEC). 5 predefined fields of view per sample were analyzed in a representative experiment. In e , CXCL9 and CXCL10 were used to induce adhesion of untreated or GDF-15-treated CD8 + T cells from 3 different donors on stimulated huLEC. In f , stimulated CD8 + T cells from 3 different donors were treated with rhGDF-15 and anti-GFRAL or isotype control antibodies for 20 min before being run in µ-slides over a layer of activated huLEC. In g – j , phase-contrast microscopy in chamber slides to assess effects of rhGDF-15 on T cell adhesion to activated HUVEC. An EC 50 value for rhGDF-15-mediated adhesion inhibition on pan T cells from 3 different donors was determined in g (logICF=logIC50 + (1/HillSlope)*log(F/(100-F)). h – j Using pan T cells from 9 different donors, effects of rhGDF-15 on T cell adhesion ( h ), transmigration ( i ) and recruitment ( j ) were analyzed. Statistical analyses were performed by one-way ANOVA in a , d , f , by two-sided paired Student´s t -tests in b , e , h , i , j , by mixed-effects analysis in c . To correct for multiple comparisons, Tukey´s post hoc test was applied in a , c , d , Bonferroni´s method in b . In c , d , g , mean values with SEM, in e , f , median values are indicated as horizontal lines. Source data are provided as a Source Data file.

Article Snippet: Fibronectin was aspirated, followed by a wash with huLEC or HUVEC medium (InSCREENeX, Braunschweig, Germany). huLEC (InSCREENeX) or HUVECs (Lonza, Basel, Switzerland or freshly isolated) were detached, washed and resuspended at 1×10 6 cells/ml.

Techniques: Recombinant, Derivative Assay, Flow Cytometry, Staining, Control, Microscopy, Inhibition, Transmigration Assay

a – c µ-slides were coated with CXCL12α and vehicle or ICAM-1-Fc ( a–c ), MAdCAM-1-Fc ( b ), or VCAM-1-Fc ( c ). Stained primary human T cells were stimulated with anti-CD3/CD28 before GDF-15, or vehicle, or antibodies against adhesion molecules LFA-1, α4β7 integrin, or VCAM-1 were added for 30 min. T cells were perfused for 6 min over the coated µ-slides. Adhesion was recorded by live microscopy and analyzed using CellProfiler software. In d , e , CD4 + and CD8 + T cells were pre-treated for 20 min with GDF-15, or blocking anti-LFA-1 antibody TS1/18, or both, and run over activated HUVEC as in ( 1e – i ). f , g Binding of conformation-specific anti-active LFA-1 antibody mAb24 ( f ) or ICAM-Fc ( g ) to CD8 + T cells was analyzed. Whole blood from healthy volunteers was maintained at 37 °C and treated or not with GDF-15 10 min prior to LFA-1 activation. Fluorescence-conjugated antibodies and complexed soluble ICAM-1-Fc were added for another 10 min. Cells were fixed and analyzed on an Attune Nxt flow cytometer. Mean fluorescent intensity (MFI) values were normalized to control conditions by z-transformation. h , i , j Human PBMC were stimulated for 30 min with CXCL12α and Mg 2+ ± rhGDF-15. Cells were stained with the conformation-specific Alexa Fluor 647-labeled anti-LFA-1 antibody mAb24 ( h ) or hICAM-1-Fc-AF647 ( i ). The number of active LFA-1 molecules per single CD3 + T cell was quantified by direct stochastic optical reconstruction microscopy. Representative single cell images are shown in h , i . Data obtained with mAb24 across three different donors are summarized in j . k , l T cells were added to ICAM-1- and E-Selectin-coated Protein G beads, in the absence or presence of GDF-15. After lysis, Talin phosphorylation was assessed by Western blotting, with CD3ε as loading control. A representative blot is shown in k . Protein quantification data from 7 different samples normalized to vehicle (human serum albumin) control are displayed in l . Statistics were calculated by Kruskal–Wallis with Dunn´s post hoc test ( a ), by one-way ANOVA with Tukey´s correction for multiple comparisons ( b–e ), and by two-sided paired t -tests ( f , g , j , l ). Horizontal bars indicate mean ( a , f , g ) or median ( d , e , j , l ) values. Source data are provided as Source Data file.

Journal: Nature Communications

Article Title: Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

doi: 10.1038/s41467-023-39817-3

Figure Lengend Snippet: a – c µ-slides were coated with CXCL12α and vehicle or ICAM-1-Fc ( a–c ), MAdCAM-1-Fc ( b ), or VCAM-1-Fc ( c ). Stained primary human T cells were stimulated with anti-CD3/CD28 before GDF-15, or vehicle, or antibodies against adhesion molecules LFA-1, α4β7 integrin, or VCAM-1 were added for 30 min. T cells were perfused for 6 min over the coated µ-slides. Adhesion was recorded by live microscopy and analyzed using CellProfiler software. In d , e , CD4 + and CD8 + T cells were pre-treated for 20 min with GDF-15, or blocking anti-LFA-1 antibody TS1/18, or both, and run over activated HUVEC as in ( 1e – i ). f , g Binding of conformation-specific anti-active LFA-1 antibody mAb24 ( f ) or ICAM-Fc ( g ) to CD8 + T cells was analyzed. Whole blood from healthy volunteers was maintained at 37 °C and treated or not with GDF-15 10 min prior to LFA-1 activation. Fluorescence-conjugated antibodies and complexed soluble ICAM-1-Fc were added for another 10 min. Cells were fixed and analyzed on an Attune Nxt flow cytometer. Mean fluorescent intensity (MFI) values were normalized to control conditions by z-transformation. h , i , j Human PBMC were stimulated for 30 min with CXCL12α and Mg 2+ ± rhGDF-15. Cells were stained with the conformation-specific Alexa Fluor 647-labeled anti-LFA-1 antibody mAb24 ( h ) or hICAM-1-Fc-AF647 ( i ). The number of active LFA-1 molecules per single CD3 + T cell was quantified by direct stochastic optical reconstruction microscopy. Representative single cell images are shown in h , i . Data obtained with mAb24 across three different donors are summarized in j . k , l T cells were added to ICAM-1- and E-Selectin-coated Protein G beads, in the absence or presence of GDF-15. After lysis, Talin phosphorylation was assessed by Western blotting, with CD3ε as loading control. A representative blot is shown in k . Protein quantification data from 7 different samples normalized to vehicle (human serum albumin) control are displayed in l . Statistics were calculated by Kruskal–Wallis with Dunn´s post hoc test ( a ), by one-way ANOVA with Tukey´s correction for multiple comparisons ( b–e ), and by two-sided paired t -tests ( f , g , j , l ). Horizontal bars indicate mean ( a , f , g ) or median ( d , e , j , l ) values. Source data are provided as Source Data file.

Article Snippet: Fibronectin was aspirated, followed by a wash with huLEC or HUVEC medium (InSCREENeX, Braunschweig, Germany). huLEC (InSCREENeX) or HUVECs (Lonza, Basel, Switzerland or freshly isolated) were detached, washed and resuspended at 1×10 6 cells/ml.

Techniques: Staining, Microscopy, Software, Blocking Assay, Binding Assay, Activation Assay, Fluorescence, Flow Cytometry, Control, Transformation Assay, Labeling, Lysis, Phospho-proteomics, Western Blot